CareDx Announces Dismissal of 2021 Qui Tam Suit
CareDx, Inc. has announced the dismissal of a qui tam lawsuit originally filed against the company. The United States District Court for the Eastern District of New York issued the dismissal order on April 23, 2026.
BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the dismissal of a qui tam action filed against the Company. On April 23, 2026, the United States District Court for the Eastern District of New York issued an order dismissing the matter. Ther